Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Reactive oxygen species generation via porphyrin photosensitization is a well-established biochemical process central to modern photodynamic therapies that leverage tunable organic chromophores for controlled oxidative damage within targeted tissues. It involves the absorption of light by porphyrin-based photosensitizers, which then transfer energy to molecular oxygen, producing cytotoxic ROS such as singlet oxygen, superoxide, peroxyl, and hydroxyl radicals. These ROS induce cell death through apoptosis, necrosis, or autophagy, making it a valuable tool for cancer therapy and antimicrobial treatments.
Light-triggered production of cytotoxic ROS via energy transfer from photoexcited porphyrin to molecular oxygen, leading to singlet oxygen and other ROS generation and subsequent cell death.
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reactive Oxygen Species Generation via Porphyrin Photosensitization (ROS Generation via Porphyrin Photosensitization).